These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8584042)

  • 21. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A; Monferini E; Borsini F
    Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists.
    Schreiber R; Brocco M; Gobert A; Veiga S; Millan MJ
    Eur J Pharmacol; 1994 Dec; 271(2-3):537-41. PubMed ID: 7705455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV; Pierce PA; Peroutka SJ
    Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
    Claustre Y; Benavides J; Scatton B
    J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
    Fowler CJ; Ahlgren PC; Brännström G
    Br J Pharmacol; 1992 Sep; 107(1):141-5. PubMed ID: 1330157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
    Zgombick JM; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.